D. A. Bremner

629 total citations
32 papers, 510 citations indexed

About

D. A. Bremner is a scholar working on Pharmacology, Epidemiology and Infectious Diseases. According to data from OpenAlex, D. A. Bremner has authored 32 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pharmacology, 9 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in D. A. Bremner's work include Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Infective Endocarditis Diagnosis and Management (5 papers). D. A. Bremner is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (10 papers), Antibiotic Resistance in Bacteria (8 papers) and Infective Endocarditis Diagnosis and Management (5 papers). D. A. Bremner collaborates with scholars based in New Zealand, Australia and India. D. A. Bremner's co-authors include S. D. R. Lang, David Haydock, G L Hill, Khem Raj Joshi, Ross A. Pettigrew, J.B. Gavin, Bryan R. Parry, G. C. Simmons, Diana Martin and Joanna Stewart and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, British journal of surgery and Journal of Antimicrobial Chemotherapy.

In The Last Decade

D. A. Bremner

31 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. A. Bremner New Zealand 15 188 122 121 92 66 32 510
A Boisivon France 10 123 0.7× 218 1.8× 165 1.4× 67 0.7× 58 0.9× 30 543
I Mimica Brazil 13 221 1.2× 48 0.4× 111 0.9× 84 0.9× 63 1.0× 41 643
Publio Toala United States 9 147 0.8× 85 0.7× 185 1.5× 85 0.9× 56 0.8× 11 440
C. H. Teoh-Chan Hong Kong 12 117 0.6× 133 1.1× 87 0.7× 60 0.7× 85 1.3× 21 497
Anna Maria Cardona Planes Spain 10 174 0.9× 201 1.6× 122 1.0× 87 0.9× 83 1.3× 18 500
Glenda Garvey United States 14 429 2.3× 46 0.4× 195 1.6× 180 2.0× 86 1.3× 17 832
Kozo Fujita Japan 11 191 1.0× 35 0.3× 184 1.5× 125 1.4× 22 0.3× 35 781
Ernestine M. Vellozzi United States 11 81 0.4× 46 0.4× 135 1.1× 74 0.8× 35 0.5× 14 396
Ivani Lúcia Leme Brazil 10 101 0.5× 130 1.1× 154 1.3× 41 0.4× 27 0.4× 13 411
James R. Tillotson United States 14 311 1.7× 33 0.3× 159 1.3× 58 0.6× 92 1.4× 23 764

Countries citing papers authored by D. A. Bremner

Since Specialization
Citations

This map shows the geographic impact of D. A. Bremner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. A. Bremner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. A. Bremner more than expected).

Fields of papers citing papers by D. A. Bremner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. A. Bremner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. A. Bremner. The network helps show where D. A. Bremner may publish in the future.

Co-authorship network of co-authors of D. A. Bremner

This figure shows the co-authorship network connecting the top 25 collaborators of D. A. Bremner. A scholar is included among the top collaborators of D. A. Bremner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. A. Bremner. D. A. Bremner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Simmons, G. C., Diana Martin, Joanna Stewart, et al.. (2001). Carriage of Neisseria meningitidis Among Household Contacts of Patients with Meningococcal Disease in New Zealand. European Journal of Clinical Microbiology & Infectious Diseases. 20(4). 237–242. 26 indexed citations
2.
Simmons, G. C., Diana Martin, Joanna Stewart, & D. A. Bremner. (2000). Carriage of N. lactamica in a population at high risk of meningococcal disease. Epidemiology and Infection. 125(1). 99–104. 15 indexed citations
3.
Taylor, Steven, et al.. (1997). Surveillance for antimicrobial resistance in enterococci.. PubMed. 110(1047). 251–3. 4 indexed citations
4.
Watson, Peter J., et al.. (1996). The microbiology of chronic otitis media with effusion in a group of Auckland children.. PubMed. 109(1022). 182–4. 13 indexed citations
5.
Bremner, D. A., et al.. (1995). The in-vitro activity of biapanem against 964 clinical isolates of aerobic bacteria. Journal of Antimicrobial Chemotherapy. 35(5). 681–686. 10 indexed citations
6.
Rose, Thierry, D. A. Bremner, James F. Collins, et al.. (1990). Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis. Journal of Antimicrobial Chemotherapy. 25(4). 657–664. 5 indexed citations
7.
Bremner, D. A., et al.. (1988). In-vitro activity of fleroxacin compared with three other quinolones. Journal of Antimicrobial Chemotherapy. 22(Supplement_D). 19–23. 17 indexed citations
8.
Bremner, D. A.. (1987). Susceptibility of gentamicin sensitive and resistant gram negative bacilli to ceftazidime. Pathology. 19(3). 274–276. 1 indexed citations
9.
Morris, Arthur J., et al.. (1986). Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum. Journal of Infection. 13(2). 151–156. 20 indexed citations
10.
Bremner, D. A., et al.. (1984). Group G streptococcal septicaemia: Report of six cases. Journal of Infection. 8(2). 173–176. 12 indexed citations
11.
Bremner, D. A., et al.. (1984). ANTIMICROBIAL MANAGEMENT OF INTRACRANIAL ABSCESS. Australian and New Zealand Journal of Surgery. 54(3). 253–255. 2 indexed citations
12.
Bremner, D. A., et al.. (1983). Treatment of complicated urinary tract infections with the long acting cephalosporin, ceftriaxone.. PubMed. 96(732). 392–4. 5 indexed citations
13.
Bremner, D. A.. (1981). Susceptibility of Clinical Isolates to Cefoperazone. Drugs. 22(Supplement 1). 29–31.
14.
Joshi, Khem Raj, et al.. (1975). The morphological identification of pathogenic yeasts using carbohydrate media.. Journal of Clinical Pathology. 28(1). 18–24. 14 indexed citations
15.
Smith, J. T., D. A. Bremner, & Naomi Datta. (1974). Ampicillin Resistance of Shigella sonnei. Antimicrobial Agents and Chemotherapy. 6(4). 418–421. 11 indexed citations
16.
Joshi, Khem Raj, J.B. Gavin, & D. A. Bremner. (1973). The formation of germ tubes by Candida albicans in various peptone media.. PubMed. 11(3). 259–62. 28 indexed citations
17.
Joshi, Khem Raj, et al.. (1973). The Formation of Germ Tubes byCandida albicansin Sheep Serum and Trypticase Soya Broth. American Journal of Clinical Pathology. 60(6). 839–842. 16 indexed citations
18.
Bremner, D. A., et al.. (1966). MYCOPLASMA PNEUMONIAE IN LOWER RESPIRATORY TRACT INFECTIONS. The Medical Journal of Australia. 2(6). 261–264. 3 indexed citations
19.
Hayward, Nancy J., et al.. (1965). RENAL LESIONS IN EXPERIMENTAL PLUMBISM AND THEIR CLINICAL IMPLICATIONS. Australasian Annals of Medicine. 14(1). 49–56. 16 indexed citations
20.
Louis, C. J. & D. A. Bremner. (1962). MIXED SALIVARY TUMOURS. Australian and New Zealand Journal of Surgery. 31(4). 254–262. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026